Patents by Inventor Stjepan Kukolja

Stjepan Kukolja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4683227
    Abstract: 7.beta.-Heterocyclicacetylamino-(and 7.beta.-heterocyclicthioacetamido)-3-chloro-3-cephem-4-carboxylic acids and pharmaceutically acceptable salts thereof, e.g., 7.beta.-[2-(2-aminothiazol-4-yl)acetamido]-3-chloro-3-cephem-4-carboxylic acid and salts thereof, exhibit surprising peroral bioavailability and are useful in a method for treating infections in man and animals and in formulations for oral administration.
    Type: Grant
    Filed: July 9, 1985
    Date of Patent: July 28, 1987
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Walter E. Wright
  • Patent number: 4501741
    Abstract: 7.beta.-[2-Amino-2-(benzothien-4,5,6, and 7-yl)acetylamino]-3-substituted-3-cepham-4-carboxylic acids and 7.beta.-[2-amino-2-(2,3-dihydrobenzothien-4,5,6, and 7 yl)acetylamino]-3H- or 3-substituted-3-cephem-4-carboxylic acids (1), e.g. 7.beta.-[2-amino-2-(benzothien-4-yl)acetylamino]-3-methyl-3-cephem-4-carbo xylic acid, are orally effective antibiotics. Also provided are benzothienyl oximino compounds, the corresponding 2,3-dihydro compounds (2) useful as intermediates to (1) and as antibiotics, as well as 7.beta.-(2,2-dialkyl-5-oxo-4-benzothienyl-1-imidazolidinyl)-3H-(3-substitu ted)-3-cephem-4-carboxylic acids and the corresponding 2,3-dihydro compounds (3) useful as antibiotics, and prepared with (1) by condensation with ketones. Pharmaceutical formulations of antibiotic compounds (1), (2), and (3) are provided.
    Type: Grant
    Filed: April 12, 1983
    Date of Patent: February 26, 1985
    Assignee: Eli Lilly and Company
    Inventors: Bernard J. Graves, Stjepan Kukolja
  • Patent number: 4492693
    Abstract: 7-(3-Benzothienyl)glycylamido cephalosporins have good gram positive activity and favorable pharmacokinetics and are orally effective.
    Type: Grant
    Filed: April 12, 1983
    Date of Patent: January 8, 1985
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, Stjepan Kukolja, Jan R. Turner
  • Patent number: 4431803
    Abstract: 7-Epi-3-exomethylenecephams are useful intermediates for synthesis of antibiotics.
    Type: Grant
    Filed: December 21, 1981
    Date of Patent: February 14, 1984
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Janice L. Pfeil
  • Patent number: 4407750
    Abstract: Aryl 4R[1-(2-N-3-methyl-4-al-Z-but-2-ene-oate)-2-oxo-3s-acylamino azetidinone]disulfides are prepared by reacting the corresponding 7.alpha.-acylamino-2.alpha.-alkoxy-3-methyl-3-cephem-4-carboxylates first with either phenylsulfenyl chloride or a monosubstituted-phenylsulfenyl chloride where the substituent is either chloro, methoxy, methyl or acetoxy. The disulfide compounds produced in this invention are intermediates in the synthesis of the 7.beta.-acylamino-7.alpha.-alkoxy-3-methyl 1-oxa .beta.-lactam acids, a class of antibiotic compounds.
    Type: Grant
    Filed: August 7, 1981
    Date of Patent: October 4, 1983
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Janice L. Pfeil
  • Patent number: 4394313
    Abstract: 4R, 4'R bis [1-(2-N-3-methyl-4-al-Z-but-2-ene-oate)-2-oxo-3S-acylamino azetidine]disulfide compounds are prepared by reacting the corresponding 7.alpha.-acylamino-2.alpha.-alkoxy-3-methyl-3-cephem-4-carboxylates first with an N-chloro halogenating agent, e.g., N-chlorosuccinimide, then with an aqueous suspension of mercury dichloride and cadmium carbonate. The disulfide compounds produced in this invention are intermediates in the synthesis of the biologically active 7.beta.-acyl-amino-7.alpha.-alkoxy-3-methyl 1-oxa .beta.-lactam antibiotic compounds.
    Type: Grant
    Filed: May 18, 1981
    Date of Patent: July 19, 1983
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Janice L. Pfeil
  • Patent number: 4368156
    Abstract: Process for 4-halo azetidinones of the formula ##STR1## wherein R.sub.1 is acylamino or diacylamino, X is chloro, bromo or iodo, and R is a carboxy-protecting group which comprises treating a 4-sulfinoazetidinone of the formula ##STR2## with positive halogen reagent, eg. N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, hypohalite. The 4-haloazetidinones are useful intermediate for .beta.-lactam antibiotics.
    Type: Grant
    Filed: March 9, 1981
    Date of Patent: January 11, 1983
    Assignee: Eli Lilly and Company
    Inventors: Wayne A. Spitzer, Stjepan Kukolja, Theodore Goodson, Jr., Steven R. Lammert
  • Patent number: 4336191
    Abstract: Novel beta-lactam compounds of the formula ##STR1## and process for their preparation in which a penicillin ester is reacted with a source of positive halogen to selectively open the thiazolidine nucleus of the penicillin.
    Type: Grant
    Filed: February 25, 1977
    Date of Patent: June 22, 1982
    Assignee: Eli Lilly and Company
    Inventor: Stjepan Kukolja
  • Patent number: 4335240
    Abstract: Azetidinone alcohol disulfides are synthesized by reduction of the corresponding aldehydes. The azetidinone alcohol disulfides are the substrates for a process which cyclizes these compounds to 1-oxa .beta.-lactam compounds, employing a cyclizing reagent chosen from the class consisting of divalent mercury salts or tri-valent phosphine compounds. The 1-oxa .beta.-lactam compounds produced by this process are intermediates in the synthesis of 1-oxa .beta.-lactam antibiotics.
    Type: Grant
    Filed: May 18, 1981
    Date of Patent: June 15, 1982
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Janice L. Pfeil
  • Patent number: 4302391
    Abstract: Aryl 4R[1-(2-N-3-methyl-4-al-Z-but-2-ene-oate)-2-oxo-3S-acylamino azetidinone]disulfides are prepared by reacting the corresponding 7.alpha.-acylamino-2.alpha.-alkoxy-3-methyl-3-cephem-4-carboxylates first with either phenylsulfenyl chloride or a monosubstituted-phenylsulfenyl chloride where the substituent is either chloro, methoxy, methyl or acetoxy. The disulfide compounds produced in this invention are intermediates in the synthesis of the 7.beta.-acylamino-7.alpha.-alkoxy-3-methyl 1-oxa .beta.-lactam acids, a class of antibiotic compounds.
    Type: Grant
    Filed: April 7, 1980
    Date of Patent: November 24, 1981
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Janice L. Pfeil
  • Patent number: 4293493
    Abstract: Azetidinone alcohol disulfides are synthesized by reduction of the corresponding aldehydes. The azetidinone alcohol disulfides are the substrates for a process which cyclizes these compounds to 1-oxa .beta.-lactam compounds, employing a cyclizing reagent chosen from the class consisting of divalent mercury salts or trivalent phosphine compounds. The 1-oxa .beta.-lactam compounds produced by this process are intermediates in the synthesis of 1-oxa .beta.-lactam antibiotics.
    Type: Grant
    Filed: April 7, 1980
    Date of Patent: October 6, 1981
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Janice L. Pfeil
  • Patent number: 4293495
    Abstract: 4R,4'R bis[1-(2-N-3-methyl-4-al-Z-but-2-ene-oate)-2-oxo-3S-acylamino azetidine]disulfide compounds are prepared by reacting the corresponding 7.alpha.-acylamino-2.alpha.-alkoxy-3-methyl-3-cephem-4-carboxylates first with an N-chloro halogenating agent, e.g., N-chlorosuccinimide, then with an aqueous suspension of mercury dichloride and cadmium carbonate. The disulfide compounds produced in this invention are intermediates in the synthesis of the biologically active 7.beta.-acylamino-7.alpha.-alkoxy-3-methyl 1-oxa .beta.-lactam antibiotic compounds.
    Type: Grant
    Filed: April 7, 1980
    Date of Patent: October 6, 1981
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Janice L. Pfeil
  • Patent number: 4165315
    Abstract: A penicillin sulfoxide ester is reacted with an N-chloro halogenating agent at a temperature of from about 75.degree. C. to about 135.degree. C. to produce a novel 2-chlorosulfinylazetidin-4-one intermediate. The intermediate can be treated with stannic chloride to produce a 3-exomethylenecepham sulfoxide.
    Type: Grant
    Filed: November 17, 1977
    Date of Patent: August 21, 1979
    Assignee: Eli Lilly and Company
    Inventor: Stjepan Kukolja
  • Patent number: 4159266
    Abstract: Penicillin sulfoxide derived azetidinone sulfinyl chlorides and related sulfinic acid derivatives are cyclized to 3-methylenecephams by reaction with Friedel-Crafts catalysts or metathetic cation forming agents.
    Type: Grant
    Filed: May 13, 1977
    Date of Patent: June 26, 1979
    Assignee: Eli Lilly and Company
    Inventor: Stjepan Kukolja
  • Patent number: 4115643
    Abstract: 7-Acylamido-3-hydroxy-3-cephem-4-carboxylic acid ester sulfoxides are chlorinated and reduced in a single step process with phosphorus trichloride in dimethylformamide to provide 7-acylamido-3-chloro-3-cephem-4-carboxylic acid ester sulfides.
    Type: Grant
    Filed: August 8, 1977
    Date of Patent: September 19, 1978
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Douglas O. Spry
  • Patent number: 4093800
    Abstract: A novel 4-(2'-benzothiazolyldithio)-3-imidoazetidin-2-one of the formula ##STR1## in which X is chloro or bromo and R.sub.2 is methylene or oxygen is ring-closed to the corresponding 3-exomethylenecepham or 3-"oxo" cepham by treatment with sodium or potassium iodide at a temperature of from about 40.degree. C. to about 80.degree. C.
    Type: Grant
    Filed: February 14, 1977
    Date of Patent: June 6, 1978
    Assignee: Eli Lilly and Company
    Inventor: Stjepan Kukolja
  • Patent number: 4081440
    Abstract: A penicillin sulfoxide ester is reacted with an N-chloro halogenating agent at a temperature of from about 75.degree. C. to about 135.degree. C. to produce a novel 2-chlorosulfinylazetidin-4-one intermediate. The intermediate can be treated with stannic chloride to produce a 3-exomethylenecepham sulfoxide.
    Type: Grant
    Filed: April 2, 1976
    Date of Patent: March 28, 1978
    Assignee: Eli Lilly and Company
    Inventor: Stjepan Kukolja
  • Patent number: 4052387
    Abstract: Penicillin sulfoxide derived azetidinone sulfinyl chlorides and related sulfinic acid derivatives are cyclized to 3-methylenecephams by reaction with Friedel-Crafts catalysts or metathetic cation forming agents.
    Type: Grant
    Filed: April 2, 1976
    Date of Patent: October 4, 1977
    Assignee: Eli Lilly and Company
    Inventor: Stjepan Kukolja
  • Patent number: 4048162
    Abstract: 3-Hydroxycephalosporins are prepared by treating a 3-hydroxy-4-bromo-2-(2-formylthio-4-oxo-3-amido or imido-1-azetidinyl)-2-butenoate ester with 1,5-diazabicyclo[3.4.0]non-5-ene (DBN) or 1,5-diazabicyclo[5.4.0]undec-5-ene (DBU) at a temperature of from about 0.degree. C. to about 25.degree. C.
    Type: Grant
    Filed: October 29, 1975
    Date of Patent: September 13, 1977
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Charles F. Murphy
  • Patent number: 4031084
    Abstract: 7-Acylamido-3-exomethylenecepham ester sulfoxides are reacted with ozone to provide the corresponding 3-hydroxy-3-cephem ester sulfoxides, intermediates for 3-methoxy and 3-halo substituted cephalosporin antibiotics; e.g., p-nitrobenzyl 7-phenoxyacetamido-3-exomethylenecepham-4-carboxylate-1-oxide provides the corresponding 3-hydroxy-3-cephem ester sulfoxide.
    Type: Grant
    Filed: October 23, 1975
    Date of Patent: June 21, 1977
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Douglas O. Spry